Sailan Zou

1.5k total citations · 1 hit paper
11 papers, 1.0k citations indexed

About

Sailan Zou is a scholar working on Molecular Biology, Cancer Research and Infectious Diseases. According to data from OpenAlex, Sailan Zou has authored 11 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cancer Research and 2 papers in Infectious Diseases. Recurrent topics in Sailan Zou's work include MicroRNA in disease regulation (5 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and RNA modifications and cancer (2 papers). Sailan Zou is often cited by papers focused on MicroRNA in disease regulation (5 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and RNA modifications and cancer (2 papers). Sailan Zou collaborates with scholars based in China and United States. Sailan Zou's co-authors include Xianghui Fu, Yan Tian, Bowen Liu, Wei Huang, Geng Liu, Dongmei Tang, Xiao Du, Guixiang Zhang, Haixia Xu and Yan Tian and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Oncogene.

In The Last Decade

Sailan Zou

11 papers receiving 1.0k citations

Hit Papers

Targeting STAT3 in Cancer... 2020 2026 2022 2024 2020 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Sailan Zou 561 348 259 226 116 11 1.0k
Junlin Yao 541 1.0× 265 0.8× 259 1.0× 311 1.4× 57 0.5× 24 1.1k
Aida S. Hansen 509 0.9× 247 0.7× 184 0.7× 172 0.8× 84 0.7× 21 903
Teruaki Fujishita 583 1.0× 408 1.2× 222 0.9× 234 1.0× 118 1.0× 23 1.1k
Ji-Young Jang 596 1.1× 207 0.6× 322 1.2× 166 0.7× 100 0.9× 18 908
Lidia Avalle 519 0.9× 491 1.4× 217 0.8× 413 1.8× 111 1.0× 25 1.1k
Jeremy A. Meier 541 1.0× 385 1.1× 185 0.7× 327 1.4× 77 0.7× 24 1.1k
Dongxian Guan 503 0.9× 255 0.7× 250 1.0× 154 0.7× 65 0.6× 17 891
Zihuan Yang 678 1.2× 272 0.8× 321 1.2× 125 0.6× 86 0.7× 57 1.1k
Wen-Juan Gan 554 1.0× 258 0.7× 240 0.9× 197 0.9× 45 0.4× 31 912
Joan Lewis-Wambi 631 1.1× 424 1.2× 323 1.2× 141 0.6× 82 0.7× 31 1.3k

Countries citing papers authored by Sailan Zou

Since Specialization
Citations

This map shows the geographic impact of Sailan Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sailan Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sailan Zou more than expected).

Fields of papers citing papers by Sailan Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sailan Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sailan Zou. The network helps show where Sailan Zou may publish in the future.

Co-authorship network of co-authors of Sailan Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Sailan Zou. A scholar is included among the top collaborators of Sailan Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sailan Zou. Sailan Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Zou, Sailan, et al.. (2025). Pathological Glucose Levels Enhance Entry Factor Expression and Hepatic SARSCoV ‐2 Infection. Journal of Cellular and Molecular Medicine. 29(11). e70581–e70581. 1 indexed citations
2.
Zou, Sailan, Guixiang Zhang, Meilin Ma, et al.. (2023). Extrachromosomal circular MiR-17-92 amplicon promotes HCC. Hepatology. 79(1). 79–95. 37 indexed citations
3.
Liu, Geng, Xiaoli Fu, Chao Dou, et al.. (2023). Targeting RNA G-quadruplex with repurposed drugs blocks SARS-CoV-2 entry. PLoS Pathogens. 19(1). e1011131–e1011131. 21 indexed citations
4.
Zou, Sailan, Yan Tian, Geng Liu, et al.. (2023). Enhanced nuclear translation is associated with proliferation and progression across multiple cancers. SHILAP Revista de lepidopterología. 4(3). e248–e248. 8 indexed citations
5.
Tian, Yan, Mingfeng Zhang, Mingjie Fan, et al.. (2022). A miRNA-mediated attenuation of hepatocarcinogenesis in both hepatocytes and Kupffer cells. Molecular Therapy — Nucleic Acids. 30. 1–12. 11 indexed citations
6.
Zhang, Yunjing, Qiongzi Qiu, Yuan Yuan, et al.. (2022). Circular RNA circDVL1 inhibits clear cell renal cell carcinoma progression through the miR-412-3p/PCDH7 axis. International Journal of Biological Sciences. 18(4). 1491–1507. 16 indexed citations
7.
Ma, Meilin, Changhui Zhang, Dongmei Tang, et al.. (2022). UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination. Oncogene. 41(48). 5199–5213. 21 indexed citations
8.
Zou, Sailan, et al.. (2020). Targeting STAT3 in Cancer Immunotherapy. Molecular Cancer. 19(1). 145–145. 741 indexed citations breakdown →
9.
Liu, Geng, Wenya Du, Haixia Xu, et al.. (2020). RNA G-quadruplex regulates microRNA-26a biogenesis and function. Journal of Hepatology. 73(2). 371–382. 43 indexed citations
10.
Xu, Haixia, Yan Tian, Dongmei Tang, et al.. (2020). An Endoplasmic Reticulum Stress–MicroRNA‐26a Feedback Circuit in NAFLD. Hepatology. 73(4). 1327–1345. 58 indexed citations
11.
Xu, Haixia, Xiao Du, Geng Liu, et al.. (2019). The pseudokinase MLKL regulates hepatic insulin sensitivity independently of inflammation. Molecular Metabolism. 23. 14–23. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026